STOCK TITAN

3,639 RSUs registered; CYTK (NASDAQ: CYTK) insider 10b5-1 sales listed

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CYTK filing notifies a proposed sale of 3,639 Restricted Stock Units dated 03/06/2026. The filing also lists multiple 10b5-1 dispositions by Andrew Callos between 01/02/2026 and 03/18/2026, including sales of 15,000 shares on 03/05/2026 and other dated transactions with reported proceeds.

Positive

  • None.

Negative

  • None.

Insights

Form 144 registers a small RSU sale and documents routine 10b5-1 dispositions.

The filing lists 3,639 Restricted Stock Units offered for sale on 03/06/2026 and shows multiple executed 10b5-1 sales by Andrew Callos from 01/02/2026 through 03/18/2026, with per‑trade proceeds reported.

These entries indicate pre‑arranged trading activity rather than ad hoc insider trading; subsequent filings or broker notices will confirm settlement and any remaining insider holdings.

RSUs registered 3,639 shares Registered for sale on 03/06/2026
Sale example 15,000 shares Sold on 03/05/2026 with proceeds of $928,062.00
Sale example 11,000 shares Sold on 03/05/2026 with proceeds of $680,639.30
Sale example 1,930 shares Sold on 03/18/2026 with proceeds of $119,803.79
Sale example 8,542 shares Sold on 03/17/2026 with proceeds of $530,885.30
Sale example 2,582 shares Sold on 03/09/2026 with proceeds of $156,779.04
10b5-1 regulatory
"10b5-1 Sales for ANDREW CALLOS 350 OYSTER POINT"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Restricted Stock Units financial
"Restricted Stock Units | Issuer | 3639 | 03/06/2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CYTK's Form 144 disclose about the RSUs?

It discloses a proposed sale of 3,639 Restricted Stock Units dated 03/06/2026. The notice registers those RSUs for sale under Rule 144 according to the filing.

Who executed recent 10b5-1 sales listed in the CYTK filing?

The filing lists multiple 10b5-1 sales by Andrew Callos between 01/02/2026 and 03/18/2026. Each transaction includes share counts and reported proceeds.

How large were some reported 10b5-1 trades in the filing?

Examples include sales of 15,000 shares on 03/05/2026 with proceeds of $928,062.00 and another 11,000-share sale the same date with proceeds of $680,639.30.

Does the Form 144 show total proceeds or aggregate shares sold?

The filing lists per‑trade share counts and proceeds but does not provide an aggregate total. Review each transaction row for individual share counts and proceeds as reported.

Are the 10b5-1 sales in the filing pre‑arranged?

The entries are labeled as 10b5-1 Sales, indicating they were executed under a pre‑arranged trading plan; the filing lists trade dates, share counts, and proceeds for each transaction.
Cytokinetics Inc

NASDAQ:CYTK

View CYTK Stock Overview

CYTK Rankings

CYTK Latest News

CYTK Latest SEC Filings

CYTK Stock Data

7.76B
120.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO